대한사람대한으로

비상장계속사업자

lnc.Daehansaramdaehaneuro

형성길

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

대한사람대한으로

Business Reg. No. 1268192077 · CEO 형성길

I.Investment Overview

Target대한사람대한으로 (1268192077)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명대한사람대한으로
영문명lnc.Daehansaramdaehaneuro
대표자형성길
사업자등록번호1268192077
법인등록번호1342110076558
설립일2001.12.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW962.12021961.82022952.920231,086.520241,1412025
영업이익100M KRW8.2202118.8202214.2202311.92024132025
순이익100M KRW-4.1202111.520228.420235.820240.92025
Item20252024202320222021
자산총계359.3억원336억원338.5억원334.3억원284.4억원
부채총계216.9억원194.5억원202.9억원207억원210.2억원
자본총계142.4억원141.5억원135.6억원127.3억원74.2억원
매출액1,141억원1,086.5억원952.9억원961.8억원962.1억원
영업이익13억원11.9억원14.2억원18.8억원8.2억원
순이익8,814만원5.8억원8.4억원11.5억원-4.1억원

VI.Financial Ratios

FY2025 basis

1.14%

영업이익률

0.08%

순이익률

0.25%

ROA

0.62%

ROE

152.39%

부채비율

39.62%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

대한사람대한으로 투심보고서 | Alpha Lenz